ABM Therapeutics is a leading innovative drug discovery company focusing on small molecule targeted therapy for the possible treatments of brain cancers including GBM, as well as brain metastasis from lung cancer, breast cancer and melanoma. Founded by an experienced group of scientists and entrepreneurs with a successful track record, they are committed to diligently search and deliver best-in-class and first-in-class medicines for the needs of patients worldwide.